ISSN 1694-8882 / e-ISSN 1694-8890
Vol. 18, No. 1, 2026 / Pages 50-72

Hypertensive crises: Opinion of the Kyrgyz society on hypertension (literature review)

cheskidova_natal@mail.ru

Received 30.09.2025
Revised 26.12.2025
Accepted 27.02.2026

Abstract

Arterial hypertension is one of the leading causes of morbidity and mortality from cardiovascular diseases worldwide, including in the Kyrgyz Republic. One of the most serious complications of this disease is a hypertensive crisis. The urgency of revising current standards is dictated by the continuing practice of overdiagnosis of “uncomplicated” crises, which leads to unnecessary hospitalisations and potentially dangerous aggressive therapy. The purpose was to summarise and present contemporary approaches based on the principles of evidence-based medicine to the definition, classification, diagnosis, and treatment of hypertensive crises to introduce them into clinical practice in the Kyrgyz Republic. The methodology was based on a systematic search, analysis, and adaptation of key clinical guidelines from the European Society of Cardiology, the European Society of Hypertension, the International Society of Hypertension, the British and Irish Hypertension Society, the American College of Cardiology, the American Heart Association, and the Russian Society of Cardiology, published between 2018 and 2025, with particular attention to their applicability in resource-limited settings. The review presented a contemporary clinical definition of hypertensive crises based solely on the presence of acute damage to target organs. The rejection of the term “uncomplicated hypertensive crisis” as an indication for emergency intravenous pressure reduction was substantiated. The algorithm of the initial assessment (identification of “red flags of target organ damage”) was described in detail, and a minimum set of laboratory and instrumental studies was regulated. A differentiated treatment strategy was proposed depending on the type of target organ damage, indicating target blood pressure levels and priority parenteral medications. Special attention was paid to the risks of uncontrolled decrease in blood pressure in inpatient and outpatient settings, and tactics for reducing pressure with an asymptomatic increase. The introduction of uniform standards will reduce inappropriate hospitalisations, improve the safety of treatment, and coordinate tactics at all levels of medical care

Keywords

hypertensive emergencies; target organ damage; emergency care; clinical guidelines; arterial hypertension; malignant hypertension

Suggested citation

APA Style
Cheskidova, N., Duishanalieva, M., Romanova, T., Jumagulova, A. & Polupanov, A. (2026). Hypertensive crises: Opinion of the Kyrgyz society on hypertension (literature review). Eurasian Health Journal, 18(1), 50-72. https://doi.org/10.54890/1694-8882-2026-1-50
Copied!
Vancouver Style
Cheskidova, N., Duishanalieva, M., Romanova, T., Jumagulova, A., Polupanov, A.. Hypertensive crises: Opinion of the Kyrgyz society on hypertension (literature review). Eurasian Health J. 2026;18(1):50-72. https://doi.org/10.54890/1694-8882-2026-1-50
Copied!

References

  1. van den Born BJH, Lip GYH, Brguljan-Hitij J, Cremer A, Segura J, Morales E, et al. ESC Council on hypertension position document on the management of hypertensive emergencies. Eur Heart J Cardiovasc Pharmacother. 2019;5(1):37–46. DOI: 10.1093/ehjcvp/pvy032
  2. Miller JB, Hrabec D, Krishnamoorthy V, Kinni H, Brook RD. Evaluation and management of hypertensive emergency. BMJ. 2024;386:e077205. DOI: 10.1136/bmj-2023-077205
  3. Mancia G, Kreutz R, Brunström M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension. J Hypertens. 2023;41(12):1874–2071. DOI: 10.1097/HJH.0000000000003480
  4. Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International society of hypertension global hypertension practice guidelines. Hypertension. 2020;75(6):1334–57. DOI: 10.1161/HYPERTENSIONAHA.120.15026
  5. Kulkarni S, Glover M, Kapil V, Abrams SML, Partridge S, McCormack T, et al. Management of hypertensive crisis: British and Irish Hypertension Society Position document. J Hum Hypertens. 2023;37(10):863–79. DOI: 10.1038/s41371-022-00776-9
  6. Kobalava ZhD, Konradi A, Nedogoda SV, Shlyakhto EV, Arutyunov G, Baranova EI, et al. Arterial hypertension in adults. Clinical guidelines 2024. Russ J Cardiol. 2024;29(9):6117. DOI: 10.15829/1560-4071-2024-6117
  7. Siddiqi TJ, Usman MS, Rashid AM, Javaid SS, Ahmed A, Clark D 3rd, et al. Clinical outcomes in hypertensive emergency: A systematic review and meta-analysis. J Am Heart Assoc. 2023;12(14):e029355. DOI: 10.1161/JAHA.122.029355
  8. McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024;45(38):3912–4018. DOI: 10.1093/eurheartj/ehae178
  9. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. Hypertension. 2018;71(6):e13–15. DOI: 10.1161/HYP.0000000000000065
  10. Astarita A, Covella M, Vallelonga F, Cesareo M, Totaro S, Ventre L, et al. Hypertensive emergencies and urgencies in emergency departments: A systematic review and meta-analysis. J Hypertens. 2020;38(7):1203–10. DOI: 10.1097/HJH.0000000000002372
  11. Gilyarevsky SR. Changing concepts in the management of acute severe blood pressure elevation without target organ damage. South Russ J Ther Pract. 2020;1(1):33–7. DOI: 10.21886/2712-8156-2020-1-1-33-37
  12. Benenson I, Waldron FA, Holly C. A systematic review and meta-analysis of the clinical and epidemiological characteristics of patients with hypertensive emergencies. High Blood Press Cardiovasc Prev. 2023;30(4):319–31. DOI: 10.1007/s40292-023-00586-1
  13. Ministry of Health of the Kyrgyz Republic. Clinical protocols of the Ministry of Health of the Kyrgyz Republic. Diagnosis and treatment of hypertension in adults [Internet]. 2024. [cited 2024 March 10]. Available from: https://med.kg/clinicalProtocolRubrikator/wuDsppQBjmg7NJ_t2OUq
  14. Narkulova GO, Gerasimova YuA, Dzhamangulova TDzh, Sharshenalieva TK, Polupanov AG. Frequency of comorbid pathology increasing cardiovascular risk in hypertensive patients. Intern Med. 2024;2:64–71. DOI: 10.54890/1694-8882-2024-2-64
  15. Magee LA, Brown MA, Hall DR, Gupta S, Hennessy A, Karumanchi SA, et al. The 2021 international society for the study of hypertension in pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2022;27:148–69. DOI: 10.1016/j.preghy.2021.09.008
  16. Carey RM. Special article – the management of resistant hypertension: A 2020 update. Prog Cardiovasc Dis. 2020;63(5):662–70. DOI: 10.1016/j.pcad.2020.08.001
  17. Rossi GP, Rossitto G, Maifredini C, Barchitta A, Bettella A, Latella R, et al. Management of hypertensive emergencies: A practical approach. Blood Press. 2021;30(4):208–19. DOI: 10.1080/08037051.2021.1917983
  18. Balahura AM, Moroi ȘI, Scafa-Udrişte A, Weiss E, Japie C, Bartoş D, et al. The management of hypertensive emergencies-is there a “magical” prescription for all? J Clin Med. 2022;11(11):3138. DOI: 10.3390/jcm11113138
  19. Boulestreau R, van den Born BH, Lip GYH, Gupta A. Malignant hypertension: Current perspectives and challenges. J Am Heart Assoc. 2022;11(7):e023397. DOI: 10.1161/JAHA.121.023397
  20. Gong F, Zheng X, Zhao S, Liu H, Chen E, Xie R, et al. Disseminated intravascular coagulation: Cause, molecular mechanism, diagnosis, and therapy. MedComm. 2025;6:e70058. DOI: 10.1002/mco2.70058
  21. San Martín-Matamoros AK, Soto-Salamanca J, Cerón-Morales JA, García-Villaseñor A, Macías-Amezcua MD. Atypical reversible posterior encephalopathy due to eclampsia. Case presentation. Encefalopatía posterior reversible atípica secundaria a eclampsia. Presentación de un caso. Cir Cir. 2020;88(1):87–90. DOI: 10.24875/CIRU.20001601
  22. Brathwaite L, Reif M. Hypertensive emergencies: A review of common presentations and treatment options. Cardiol Clin. 2019;37(3):275–86. DOI: 10.1016/j.ccl.2019.04.003
  23. Chazova IE, Chikhladze NM, Blinova NV, Belaya Zh, Danilov NM, Elfimova E, et al. Eurasian clinical guidelines for the diagnosis and treatment of secondary (symptomatic) forms of arterial hypertension (2022). Eurasian Heart J. 2023;1:6–65. DOI: 10.38109/2225-1685-2023-1-6-65
  24. Peixoto AJ. Acute severe hypertension. N Engl J Med. 2019;381(19):1843–52. DOI: 10.1056/NEJMcp1901117
  25. Davies EA, Charlesworth M, Agarwal S. Hypertensive emergencies. BJA Educ. 2024;24(10):371–80. DOI: 10.1016/j.bjae.2024.07.002
  26. Bress AP, Anderson TS, Flack JM, Ghazi L, Hall ME, Laffer CL, et al. The management of elevated blood pressure in the acute care setting: A scientific statement from the American Heart Association. Hypertension. 2024;81(8):e94–106. DOI: 10.1161/HYP.0000000000000238
  27. Stergiou GS, Palatini P, Parati G, O’Brien E, Januszewicz A, Lurbe E, et al. 2021 European society of hypertension practice guidelines for office and out-of-office blood pressure measurement. J Hypertens. 2021;39(7):1293–302. DOI: 10.1097/HJH.0000000000002843
  28. Grassi G, Dell’Oro R, Quarti-Trevano F, Vanoli J, Oparil S. Sympathetic neural mechanisms in hypertension: Recent insights. Curr Hypertens Rep. 2023;25(10):263–70. DOI: 10.1007/s11906-023-01254-4
  29. Talle MA, Doubell AF, Robbertse PS, Lahri S, Herbst PG. The role of cardiac biomarkers in the diagnosis of hypertensive emergency. Diagnostics (Basel). 2023;13(9):1605. DOI: 10.3390/diagnostics13091605
  30. Wang TJ, Gona P, Larson MG, Tofler GH, Levy D, Newton-Cheh C, et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med. 2006;355(25):2631–9. DOI: 10.1056/NEJMoa055373
  31. Murai S, Kakeshita K, Imamura T, Koike T, Fujioka H, Yamazaki H, et al. Malignant hypertension and bilateral primary aldosteronism. Intern Med. 2023;62(18):2675–80. DOI: 10.2169/internalmedicine.1098-22
  32. Fischer M, Schmutzhard E. Posterior reversible encephalopathy syndrome. J Neurol. 2017;264(8):1608–16. DOI: 10.1007/s00415-016-8377-8
  33. Mazzolai L, Teixido-Tura G, Lanzi S, Boc V, Bossone E, Brodmann M, et al. 2024 ESC guidelines for the management of peripheral arterial and aortic diseases. Eur Heart J. 2024;45(36):3538–700. DOI: 10.1093/eurheartj/ehae179
  34. Berge E, Whiteley W, Audebert H, De Marchis GM, Fonseca AC, Padiglioni C, et al. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke. Eur Stroke J. 2021;6(1). DOI: 10.1177/2396987321989865
  35. LeCouffe NE, Kappelhof M, Treurniet KM, Lingsma HF, Zhang G, van den Wijngaard IR, et al. 2B, 2C, or 3: What should be the angiographic target for endovascular treatment in ischemic stroke? Stroke. 2020;51(6):1790–6. DOI: 10.1161/STROKEAHA.119.028891
  36. Mistry EA, Hart KW, Davis LT, Gao Y, Prestigiacomo CJ, Mittal S, et al. Blood pressure control after endovascular therapy for acute ischemic stroke: The BEST-II randomized clinical trial. JAMA. 2023;330(9):821–31. DOI: 10.1001/jama.2023.14330
  37. Song L, Hu X, Ma L, Chen X, Ouyang M, Billot L, et al. INTEnsive care bundle with blood pressure reduction in acute cerebral hemorrhage trial (INTERACT3). Trials. 2021;22:943. DOI: 10.1186/s13063-021-05881-7
  38. Ma L, Hu X, Song L, Chen X, Ouyang M, Billot L, et al. The third intensive care bundle with blood pressure reduction in acute cerebral haemorrhage trial (INTERACT3). Lancet. 2023;402(10395):27–40. DOI: 10.1016/S0140-6736(23)00806-1
  39. Moullaali TJ, Wang X, Sandset EC, Woodhouse LJ, Law ZK, Arima H, et al. Early lowering of blood pressure after acute intracerebral haemorrhage. J Neurol Neurosurg Psychiatry. 2022;93(1):6–13. DOI: 10.1136/jnnp-2021-327195
  40. Qureshi AI, Huang W, Lobanova I, Barsan WG, Hanley DF, Hsu CY, et al. Outcomes of intensive systolic blood pressure reduction in patients with intracerebral hemorrhage. JAMA Neurol. 2020;77(11):1355–65. DOI: 10.1001/jamaneurol.2020.3075
  41. Ascanio LCM, Enriquez-Marulanda A, Maragkos GA, Salem MM, Alturki AY, Ravindran K, et al. Effect of blood pressure variability during the acute period of subarachnoid hemorrhage. Neurosurgery. 2020;87(4):779–87. DOI: 10.1093/neuros/nyaa019
  42. Inamasu J, Nakamura Y, Saito R, Kuroshima Y, Mayanagi K, Ichikizaki K. Endovascular treatment for poorest-grade subarachnoid hemorrhage in the acute stage. Neurosurgery. 2002;50(6):1199–206. DOI: 10.1097/00006123-200206000-00005
  43. Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart J Acute Cardiovasc Care. 2024;13(1):55–161. DOI: 10.1093/ehjacc/zuad107
  44. Levy P, Compton S, Welch R, Delgado G, Jennett A, Penugonda N, et al. Treatment of severe decompensated heart failure with high-dose intravenous nitroglycerin. Ann Emerg Med. 2007;50(2):144–52. DOI: 10.1016/j.annemergmed.2007.02.022
  45. Bossone E, Eagle KA. Epidemiology and management of aortic disease. Nat Rev Cardiol. 2021;18(5):331–48. DOI: 10.1038/s41569-020-00472-6
  46. Bartikoski SR, Reschke DJ. Pheochromocytoma crisis in the emergency department. Cureus. 2021;13(3):e13683. DOI: 10.7759/cureus.13683
  47. Diaz-Arocutipa C. Treatment of hypertensive crisis in primary care health facilities in Peru, 2019-2024. High Blood Press Cardiovasc Prev. 2026;33(2):183–93. DOI: 10.1007/s40292-025-00763-4
  48. Paštrović F, Okštajner PK, Vodanović M, Raos D, Jug J, Lovrić Benčić M, et al. The role of anxiolytics in hypertensive urgency management. Psychiatr Danub. 2020;32:593–6.
  49. Anderson TS, Herzig SJ, Jing B, Boscardin WJ, Fung K, Marcantonio ER, et al. Clinical outcomes of intensive inpatient blood pressure management in hospitalized older adults. JAMA Intern Med. 2023;183(7):715–23. DOI: 10.1001/jamainternmed.2023.1667
  50. Chaganti B, Lange RA. Treatment of hypertension among non-cardiac hospitalized patients. Curr Cardiol Rep. 2022;24(7):801–5. DOI: 10.1007/s11886-022-01699-0
  51. Weder AB, Erickson S. Treatment of hypertension in the inpatient setting: Use of intravenous labetalol and hydralazine. J Clin Hypertens (Greenwich). 2010;12(1):29–33. DOI: 10.1111/j.1751-7176.2009.00196.x
  52. Sanders RD, Hughes F, Shaw A, Thompson A, Bader A, Hoeft A, et al. Perioperative quality initiative consensus statement on preoperative blood pressure, risk and outcomes for elective surgery. Br J Anaesth. 2019;12(5):552–62. DOI: 10.1016/j.bja.2019.01.018
  53. Blessberger H, Lewis SR, Pritchard MW, Fawcett LJ, Domanovits H, Schlager O, et al. Perioperative beta-blockers for preventing surgery-related mortality and morbidity in adults undergoing non-cardiac surgery. Cochrane Database Syst Rev. 2019;9(9):CD013438. DOI: 10.1002/14651858.CD013438
  54. Kertai MD, Cooter M, Pollard RJ, Buhrman W, Aronson S, Mathew JP, et al. Is adherence to a surgical care improvement project measure for the perioperative administration of β-blockers associated with a lower rate of cardiovascular-related mortality and critical quality indicators after noncardiac surgery? Anesth Analg. 2018;126(6):1829–38. DOI: 10.1213/ANE.0000000000002577
  55. McEvoy MD, Gupta R, Koepke EJ, Feldheiser A, Michard F, Levett D, et al. Perioperative quality initiative consensus statement on postoperative blood pressure, risk and outcomes for elective surgery. Br J Anaesth. 2019;122(5):575–86. DOI: 10.1016/j.bja.2019.01.019
  56. Mamatov SM, Murzaibragimova MM, Arstanbekova MA, Smailova DK. Prevention of cardiovascular disease in aging (literature review). Eurasian Heart J. 2024;4:41–9. DOI: 10.54890/1694-8882-2024-5-41
  57. Murzaibragimova MM, Musakeev AO, Arstanbekova MA, Mamatov SM. Prevalence of cognitive impairments in elderly patients with arterial hypertension. Eurasian Heart J. 2024;4:50–5. DOI: 10.54890/1694-8882-2024-5-41